Medicare Fraudsters Now Tap Telemedicine In Medical Equipment Scams
Scammers bent on defrauding Medicare are embracing the new technologies of remote diagnosis. Federal law enforcement is cracking down.
The independent source for health policy research, polling, and news.
1,921-1,940 of 4,053 results
Scammers bent on defrauding Medicare are embracing the new technologies of remote diagnosis. Federal law enforcement is cracking down.
Eight years ago, a new medical program opened in Salina, Kan., as an experimental way to promote rural medicine. Hailed as a solution to the rural doctor shortage, only three of its eight newly minted doctors are now working in the most rural communities.
The president’s directive, which he said is designed to give beneficiaries more choices in their health care, could lead to higher costs for seniors. Final rules are to be written by the Department of Health and Human Services.
Obria, a Christian medical chain, was awarded federal family planning funds for its California clinics for the first time this year. Clinics receiving Title X funds are expected to treat and prevent sexually transmitted diseases. Obria’s prohibition against condoms means its prevention efforts rest on abstinence, even as STD rates surge.
President Donald Trump, dogged by an impeachment inquiry, tries to change the subject by unveiling an executive order aimed at expanding the role of private Medicare health plans. The Trump administration also launched an effort this week to expand “wellness” programs aimed at getting people with insurance to practice better health habits – even though research has shown the efforts don’t generally improve health or save money. This week, Alice Miranda Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
Starting today, Medicare is keeping half a billion dollars in payments from 83% of general hospitals for having too many patients come back.
KHN Midwest correspondent Lauren Weber joined StateImpact Oklahoma reporter Jackie Fortiér to discuss why a series of rural hospitals collapsed, leaving hundreds of residents without jobs and their communities without lifesaving emergency medical care.
The Freedom of Information Act lawsuit could spur the Centers for Medicare & Medicaid Services to release audits that document up to $650 million in overcharges.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
More insurers are experimenting with paying health care providers one lump sum to cover the cost of maternity care. Physicians and insurers hope the model — known as bundled payments — will help improve health outcomes.
Ride-sharing companies promise better service for enrollees and lower costs for states. But the services are not for everyone on Medicaid.
Naltrexone, commonly used for opioid and alcohol use disorders, may also help patients with chronic pain — when prescribed in low doses. But few doctors or patients seem to know about it.
Without the teamwork, communication and quick action of several veteran health officials in Wisconsin, the world might not know about the vaping illness the U.S. is battling today. This is their story.
The House speaker announced her plan for lowering drug prices, which includes negotiations between drugmakers and federal health officials.
Programs for health care professionals addicted to opioids generally bar a proven recovery method: the use of drugs like buprenorphine and methadone to relieve cravings.
Barbara Van Rooyan lost her son to the drug 15 years ago and has fought ceaselessly since then to hold Purdue Pharma accountable for its role in the opioid crisis.
State regulators and even one medevac company have raised doubts about prepaid subscriptions and promised benefits offered by air ambulance companies.
But critics say the new policy still leaves some patients exposed to lawsuits and crippling bills.
KHN reported this week that the University of Virginia Health System has filed 36,000 lawsuits against patients the past six years.
In the first six months of this year, pharmaceutical firms and their trade groups donated almost $4 million to the campaigns of a variety of senators and House members.
© 2026 KFF